Dr. Isabelle Raymond Appointed Vice President, Clinical Development of Sensus Hedalthcare

May 8, 2018

Dr. Isabelle Raymond, Ph.D., has been appointed Vice President, Clinical Development of Sensus Healthcare.

Dr. Isabelle Raymond will report to Joe Sardano, Sensus CEO, brings 14 years of medical device and pharmaceutical industry experience to the Company.

“With Isabelle’s vast strategic, hands-on expertise in an array of roles and functions across clinical research, product launches and business development, she is well-positioned to build and lead Sensus’ clinical and scientific program in 2018 and beyond,” said Sardano. “As Sensus continues to expand its product portfolio and penetrate new markets all over the world, we’re taking great pains to select the right team to get the job done. Isabelle’s in-depth experience with pharmaceutical and biotech companies of all sizes, along with her focus on dermatology and aesthetic medicine, make her the ideal addition to cultivate new relationships, spearhead new development efforts and, ultimately, drive the Company forward in the next stage of our evolution.”

An author and scientific leader in the pharmaceutical industry, Dr. Raymond joins Sensus from Exeltis, where she focused on medical dermatology and infectious diseases, building the company’s medical affairs department from the ground up. Prior to Exeltis, she served as Senior Medical Scientific Liaison at Valeant Pharmaceuticals, where her work concentrated on medical dermatology and aesthetic medicine. Dr. Raymond also served in a variety of other roles of increasing importance at EternoGen, Myoscience, Merz Pharmaceuticals and King Pharmaceuticals over the years.

“Given the recent launch of Sensus Laser Systems, which gives patients the full spectrum of clinical and aesthetic dermatological solutions, joining Sensus is a perfect and natural fit for me at this point in my career, and I look forward to contributing my industry knowledge to further the Company’s mission,” added Dr. Raymond. “Sensus is truly a game-changer when it comes to finding safe, highly effective and innovative ways to improve the lives of patients all over the world who suffer from skin conditions, and I am eager to hit the ground running and lend a hand in these meaningful initiatives.”

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version